VAERS Explorer
Back to explore

Report #2844995

Received Jun 13, 2025

Office visit
A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
29 yrs
State
CA
Recovered
Recovered
Vaccinated
Jun 13, 2025
Onset
Jun 13, 2025
Days to onset
0
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (HEPLISAV-B)DYNAVAX TECHNOLOGIES CORPORATION1946060IM / LA
TDAPTDAP (ADACEL)SANOFI PASTEUR1U8389AAIM / LA

Symptoms (2)

DyspnoeaUrticaria

Symptom narrative

- Patient having hives within 15 minutes after heplisav and tdap vaccines - Benadryl 50mg given in office and instruction was given to provider partners to monitor for 30 min - about 20 min after administration of benadryl patient reported respiratory difficulty, 0.3mg intramuscular epi was given at that time. - Patient endorsed improvement of symptoms, team continued to monitor patient for 30 minutes after epi administration. - Patient reported symptoms had not returned at time of discharge, 30 min after intramuscular epi injection - Patient discharged in stable condition with strict ED precautions.

Current illness

none

Medical history

none

Other medications

None

Allergies

none

Lab data

no